168 related articles for article (PubMed ID: 19730362)
1. Revisiting the immunophenotype of nephrogenic adenoma.
Fromont G; Barcat L; Gaudin J; Irani J
Am J Surg Pathol; 2009 Nov; 33(11):1654-8. PubMed ID: 19730362
[TBL] [Abstract][Full Text] [Related]
2. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic adenoma: an immunohistochemical analysis using biotin-free methods.
Ortiz-Rey JA; Antón-Badiola I; Pérez-Pedrosa A; Peteiro-Cancelo Á; González-Carreró J
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):386-91. PubMed ID: 22495376
[TBL] [Abstract][Full Text] [Related]
4. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic adenoma of the urinary tract: a review.
Alexiev BA; LeVea CM
Int J Surg Pathol; 2012 Apr; 20(2):123-31. PubMed ID: 22415059
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
[TBL] [Abstract][Full Text] [Related]
8. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma.
Gupta A; Wang HL; Policarpio-Nicolas ML; Tretiakova MS; Papavero V; Pins MR; Jiang Z; Humphrey PA; Cheng L; Yang XJ
Am J Surg Pathol; 2004 Sep; 28(9):1224-9. PubMed ID: 15316323
[TBL] [Abstract][Full Text] [Related]
12. Abundant expression of AMACR in many distinct tumour types.
Went PT; Sauter G; Oberholzer M; Bubendorf L
Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenoma: an update on an innocuous but troublesome entity.
Rahemtullah A; Oliva E
Adv Anat Pathol; 2006 Sep; 13(5):247-55. PubMed ID: 16998318
[TBL] [Abstract][Full Text] [Related]
14. Expression of alpha-methylacyl-CoA racemase (P504S) in nephrogenic adenoma: a significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma.
Skinnider BF; Oliva E; Young RH; Amin MB
Am J Surg Pathol; 2004 Jun; 28(6):701-5. PubMed ID: 15166661
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
Kaić G; Tomasović-Loncarić C
Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
[TBL] [Abstract][Full Text] [Related]
17. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
18. Fibromyxoid nephrogenic adenoma: a newly recognized variant mimicking mucinous adenocarcinoma.
Hansel DE; Nadasdy T; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1231-7. PubMed ID: 17667548
[TBL] [Abstract][Full Text] [Related]
19. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
20. Alpha-methyl CoA racemase expression in renal cell carcinomas.
Molinié V; Balaton A; Rotman S; Mansouri D; De Pinieux I; Homsi T; Guillou L
Hum Pathol; 2006 Jun; 37(6):698-703. PubMed ID: 16733210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
